Perioperative Music Therapy Plus Oxycodone in Perioperative Management of Lung Surgery
Effects of Music Therapy on Perioperative Anxiety and Pain Management in Lung Surgery: A Randomized, Prospective, Multidisciplinary Trial
1 other identifier
interventional
66
1 country
1
Brief Summary
To explore the feasibility and effectiveness of Perioperative Music Therapy Plus Oxycodone in pain management after thoracic surgery, patients will be randomly assigned into two groups. The experimental group will receive perioperative music therapy and the control group will not. We will record and contrast the postoperative oxycodone usage to evaluate the effect of music therapy in relieving the pain. We will also use visual analogue scale, questionnaire and EEG to evaluate patients' anxiety and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2023
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2024
CompletedJuly 17, 2024
July 1, 2024
6 months
July 31, 2023
July 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The total dose of oxycodone within 48 hours after surgery
The total dose of oxycodone within 48 hours after surgery
48 hours after surgery
Secondary Outcomes (7)
The VSA-A Score
From 1 day before surgery to the third day after surgery
The VSA-P Score
From the first day to the third day after surgery
The incidence rate of analgesic related adverse reaction
48 hours after surgery
The usage of extra analgesics after surgery
48 hours after surgery
The kind and usage of anesthetics for anesthesia induction and maintenance
During the surgery
- +2 more secondary outcomes
Other Outcomes (2)
Changes of resting beta power of electroencephalography in the central brain areas by preoperative treatment
1 hour before surgery
Changes of resting beta power of electroencephalography in the frontal midline brain areas by preoperative treatment
1 hour before surgery
Study Arms (2)
Oxycodone with Perioperative Music Therapy
EXPERIMENTALUsing perioperative music therapy plus oxycodone to manage the postoperative pain
Oxycodone without Perioperative Music Therapy
NO INTERVENTIONUsing oxycodone only to manage the postoperative pain
Interventions
Music therapist will play customized music in the perioperative period on the basis of oxycodone analgesia
Eligibility Criteria
You may qualify if:
- Enhanced CT or PET/CT indicate primary malignant pulmonary nodule;
- The clinical stage belongs to cT1-4N0-2M0 before treatment or ycT1-4N0-2M0 after neoadjuvant treatment (AJCC/TNM 8th Edition);
- Suitable for video-assisted thoracoscopic surgery after evaluated by thoracic surgeon;
- FEV1 \> 1.5L and DLCO \> 60% pred;
- Hearing loss lesser than 35 decibels (dB) in the better hearing ear;
- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2;
- American Society of Anesthesiologists Score of 1 or 2;
- Confirmed eligibility for R0 resection for curative intent by thoracic surgeon assessment;
- Adequate cardiopulmonary function, confirmed to meet the requirement for surgical resection for curative intent;
- Able to provide written informed consent and able to understand and agree to comply with study requirements and evaluation forms;
- Life expectancy greater than 12 months
You may not qualify if:
- Enhanced CT or PET/CT indicate metastatic malignant pulmonary nodule;
- Hearing loss greater than 35 decibels (dB) in the better hearing ear;
- Active autoimmune disease or history of autoimmune disease that may recur; Note: well-controlled type 1 diabetes is allowed; hypothyroidism (controlled with thyroid hormone replacement only); well-controlled celiac disease; skin disease not requiring systemic treatment (eg, vitiligo, psoriasis, alopecia); any other condition that is not expected to recur in the absence of an external trigger.
- History of interstitial lung disease, pneumonitis or uncontrolled systemic diseases, including diabetes, hypertension, pulmonary fibrosis, acute lung disease;
- Serious infection occurred before grouping, including but not limited to hospitalization due to infectious complications, bacteremia or severe pneumonia; severe chronic or active infection (including pulmonary tuberculosis infection, etc.) requiring systemic (oral or intravenous) antibiotics within 14 days before grouping;
- Simultaneous participation in another therapeutic clinical study;
- Pregnant or lactating women, or male and female patients planning to have children during the study;
- Other conditions that the investigators consider inappropriate for participation in this trial, such as poor compliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hao Longlead
- Sun Yat-sen University School of Artcollaborator
- Sun Yat-sen University Department of Psychologycollaborator
Study Sites (1)
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510000, China
Related Publications (2)
Palmer JB, Lane D, Mayo D, Schluchter M, Leeming R. Effects of Music Therapy on Anesthesia Requirements and Anxiety in Women Undergoing Ambulatory Breast Surgery for Cancer Diagnosis and Treatment: A Randomized Controlled Trial. J Clin Oncol. 2015 Oct 1;33(28):3162-8. doi: 10.1200/JCO.2014.59.6049. Epub 2015 Aug 17.
PMID: 26282640BACKGROUNDZhou W, Ye C, Wang H, Mao Y, Zhang W, Liu A, Yang CL, Li T, Hayashi L, Zhao W, Chen L, Liu Y, Tao W, Zhang Z. Sound induces analgesia through corticothalamic circuits. Science. 2022 Jul 8;377(6602):198-204. doi: 10.1126/science.abn4663. Epub 2022 Jul 7.
PMID: 35857536RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
July 31, 2023
First Posted
August 8, 2023
Study Start
August 1, 2023
Primary Completion
January 20, 2024
Study Completion
April 20, 2024
Last Updated
July 17, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share